US Patent Issued to INTRA-CELLULAR THERAPIES on July 21 for "Organic compounds" (California, New Jersey Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,731, issued on July 21, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).

"Organic compounds" was invented by Peng Li (New Milford, N.J.) and Robert Davis (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to particular substituted deuterated heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT2A receptor, serotonin transporter (SERT) and/or pathways involving dopamine D1/D2 receptor signaling systems, and/or...